SEC Form 4 · accession 0001140361-15-007860
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan W Ayers
Officer — Chairman, President & CEO · Director
Period of report
Feb 14, 2015
Accepted (ET)
Feb 18, 2015 · 6:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2015 | M | 887 | $0.00 | A | 432,017 | D | |
| Common Stock | Feb 14, 2015 | M | 1,080 | $0.00 | A | 433,097 | D | |
| Common Stock | Feb 14, 2015 | M | 1,200 | $0.00 | A | 434,297 | D | |
| Common Stock | Feb 14, 2015 | M | 1,200 | $0.00 | A | 435,497 | D | |
| Common Stock | Feb 14, 2015 | M | 1,600 | $0.00 | A | 437,097 | D | |
| Common Stock | Feb 14, 2015 | F | 2,974 | $159.08 | D | 434,123 | D | |
| Common Stock | holding | — | — | — | 49,000 | I | By Ayers Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $159.08 | Feb 14, 2015 | A | 74,316 | A | — | Feb 13, 2025 | Common Stock | 74,316 | 74,316 | D |
| Incentive Stock Option (right to buy)F2 | $159.08 | Feb 14, 2015 | A | 628 | A | — | Feb 13, 2025 | Common Stock | 628 | 628 | D |
| Restricted Stock UnitF3 | — | Feb 14, 2015 | M | 887 | D | — | — | Common Stock | 887 | 15,468 | D |
| Restricted Stock UnitF4 | — | Feb 14, 2015 | M | 1,080 | D | — | — | Common Stock | 1,080 | 14,388 | D |
| Restricted Stock UnitF5 | — | Feb 14, 2015 | M | 1,200 | D | — | — | Common Stock | 1,200 | 13,188 | D |
| Restricted Stock UnitF6 | — | Feb 14, 2015 | M | 1,200 | D | — | — | Common Stock | 1,200 | 11,988 | D |
| Restricted Stock UnitF7 | — | Feb 14, 2015 | M | 1,600 | D | — | — | Common Stock | 1,600 | 10,388 | D |
Explanation of responses
- F1Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that becomes exercisable as to 14,989 shares on 02/14/2016, 02/14/2017, 02/14/2018 and 02/14/2019, and the remaining 14,360 shares on 02/14/2020.
- F2Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests on the fifth anniversary date (02/14/2020) of the grant.
- F3Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2015) of the date of grant.
- F4Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
- F5Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
- F6Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
- F7Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vested in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.